101. Red Cells and Erythropoiesis, Excluding Iron: Poster III
0 activities
Arginine Metabolism Is a Biomarker of Red Blood Cell and Human Aging
1 activities
Arginine Metabolism Is a Biomarker of Red Blood Cell and Human Aging
Ex Vivo Glucose Tracing in Red Blood Cells from Patients with Hereditary Xerocytosis Reveals Enhanced Glycolytic Flux
1 activities
Ex Vivo Glucose Tracing in Red Blood Cells from Patients with Hereditary Xerocytosis Reveals Enhanced Glycolytic Flux
Got Oxygen? the Impact of Band 3 on RBC Function during Exercise
1 activities
Got Oxygen? the Impact of Band 3 on RBC Function during Exercise
Hereditary Erythrocytosis: Results from Europe's Largest Idiopathic Erythrocytosis Database
1 activities
Hereditary Erythrocytosis: Results from Europe's Largest Idiopathic Erythrocytosis Database
Mixed Type Autoimmune Hemolytic Anemia: A Single Center Observational Study
1 activities
Mixed Type Autoimmune Hemolytic Anemia: A Single Center Observational Study
PIEZO1 Gain-of-Function Variants Lead to Alterations in Late-Stage Erythropoiesis By Enhancing Enucleation Rate
1 activities
PIEZO1 Gain-of-Function Variants Lead to Alterations in Late-Stage Erythropoiesis By Enhancing Enucleation Rate
Part a Efficacy and Safety of Oral Bruton Tyrosine Kinase Inhibitor (BTKi) Rilzabrutinib in Patients with Warm Autoimmune Hemolytic Anemia (wAIHA): Multicenter, Open-Label, Phase 2b Study
1 activities
Part a Efficacy and Safety of Oral Bruton Tyrosine Kinase Inhibitor (BTKi) Rilzabrutinib in Patients with Warm Autoimmune Hemolytic Anemia (wAIHA): Multicenter, Open-Label, Phase 2b Study
Protein S Enhances the Phagocytosis of Phosphatidylserine-Positive Erythrocyte: Implications for the Erythrocytes Turnover
1 activities
Protein S Enhances the Phagocytosis of Phosphatidylserine-Positive Erythrocyte: Implications for the Erythrocytes Turnover
Satisfy: A Eurobloodnet Multicenter, Single-Arm Phase 2 Trial of Mitapivat in Adult Patients with Erythrocyte Membranopathies and Congenital Dyserythropoietic Anemia Type II – Results from the 8-Week Dose-Escalation Period
1 activities
Satisfy: A Eurobloodnet Multicenter, Single-Arm Phase 2 Trial of Mitapivat in Adult Patients with Erythrocyte Membranopathies and Congenital Dyserythropoietic Anemia Type II – Results from the 8-Week Dose-Escalation Period
Sirolimus Plus Roxadustat in Patients with Pure Red Cell Aplasia: Results from a Prospective Multi-Center Clinical Trial
1 activities
Sirolimus Plus Roxadustat in Patients with Pure Red Cell Aplasia: Results from a Prospective Multi-Center Clinical Trial
The Safety of Repurposing Daratumumab for Relapsed or Refractory Autoimmune-Antibody-Mediated Hemolytic Anemia
1 activities
The Safety of Repurposing Daratumumab for Relapsed or Refractory Autoimmune-Antibody-Mediated Hemolytic Anemia
Transcriptional Control of Erythropoiesis Via a Kit-Response Cistrome
1 activities
Transcriptional Control of Erythropoiesis Via a Kit-Response Cistrome
ULK1 Regulates the Proliferation and Differentiation of Erythroid Progenitors
1 activities
ULK1 Regulates the Proliferation and Differentiation of Erythroid Progenitors